Delivery Order SPE2DB22D2005-SPE2DB25FJST5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,053.12 to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets in quantities of 100 on July 28, 2025, with completion expected by July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,271.71 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100. This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a competitively awarded, non-set-aside procurement executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,144.26 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 15 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of July 29, 2025. The delivery order was issued on July 28, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of dextroamphetamine-amphetamine 15 mg tablets in quantities of 100 units, with a contract value of $2,381.06 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a standard pharmaceutical procurement through the federal medical supply chain with no set-aside designation. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100-count) with a ceiling value of $2,446.15. This firm fixed-price delivery order, which is not set-aside, represents a routine pharmaceutical procurement under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The order will be fulfilled...
- The Defense Logistics Agency awarded a delivery order valued at $1,461.30 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 units. This contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100, valued at $1,242.74. This is a firm fixed price delivery order with an ultimate completion date of July 23, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,430.14 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed price contract represents a non-set-aside procurement and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Dextroamphetamine-Amphetamine 5 mg tablets in quantities of 100s, with a ceiling value of $4,627.63 and an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for dextroamphetamine-amphetamine 10 mg tablets (100-count packages) valued at $1,859.55 with an ultimate completion date of August 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJST5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100, with a ceiling value of $1,687.28. This firm fixed price delivery order, which represents a non-set-aside competitive award, is expected to be completed by August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts primarily with the Defense Logistics Agency. The company's demonstrated capability to compete successfully for federal pharmaceutical procurement across multiple therapeutic domains—including neurological treatments, pain management, and specialty medications—positions it as a critical vendor for military and veteran healthcare systems. This delivery order represents routine pharmaceutical fulfillment under the company's established DLA contract vehicle, supporting the supply of controlled pharmaceutical substances to federal medical customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/27/25 |